~~<i id='A6ACBF2DD5'><strike id='A6ACBF2DD5'><tt id='A6ACBF2DD5'><pre id='A6ACBF2DD5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：leisure time 2025-09-30 16:23:20 - browse：4

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Slain Parkland victim's father speaks out following reenactment

knowledge

leisure time

focus

hotspot

0:25FTXFounderSamBankman-FriedarrivesatManhattanFederalCourtforacourtappearanceonJuly26,2023inNewYor

WSS

Surge in Apellis stock fueled by confidence in safety of its eye drug

BMS, looking to build heart drug business, turns to AI for diagnosis

Biogen’s boardroom scandal saddles CEO with first crisis

Medical schools are missing the mark on artificial intelligence

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Bird flu researchers hone in on Finland’s mink farms

explore

fashion

knowledge

Psychedelics group wrestles with new pharma identity

Medical mystery: When an infection after surgery isn’t what it seems

Anesthesiologist group: stop taking Ozempic before surgery

Surge in Apellis stock fueled by confidence in safety of its eye drug

Medical leaders decry Supreme Court decision on affirmative action

Dozens dead from Maui wildfires: What we know about the victims

The cancer drug shortage isn’t new — and neither are the solutions

Medical mystery: When an infection after surgery isn’t what it seems

In Memoriam: Notable people who died in 2023

Parkland mass shooting to be reenacted for lawsuit

knowledge

Schizophrenia gene found to be linked to cells' energy dysfunction

Hospitals are dialing back on venture capital investing

Lifetime voting ban for felony convictions struck down in Mississippi

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

YouTube cracks down on misinformation on cancer treatment

Mark Cuban is blaming the wrong people for high drug costs

leisure time

leisure time

focus

hotspot